https://www.americanthinker.com/blog/2021/08/a_new_covid_treatment.html
Is REGEN-COV the answer to COVID?
Nearly a year and a half has passed and over 618,000 COVID-19 related deaths were recorded in the U.S. alone and finally the FDA released an emergency use authorization for REGEN-COV; a new drug that was undergoing testing in 2020 (pre-Biden). It is now an early treatment option for primary care physicians. Until this point, the only authorized COVID-19 treatment my family doctor had per the July 2021 update to NIH guidelines was recommend quarantine, wait until symptoms go away or report to a hospital if they get worse. It is noteworthy that these updated guidelines continue to name hydroxychloroquine (HCQ) as a prohibited drug, but should be no surprise considering a war on HCQ began soon after President Trump dared to recommend it.
However, REGEN-COV is no simple take-home medicine like the familiar Tamiflu frequently prescribed for the seasonal flu. For example, (in the ‘old days’ that ended in March 2020), my wife and I both caught the seasonal flu. Our doctor immediately prescribed Tamiflu and azithromycin because he knew a delay of even a few days would make Tamiflu less effective. REGEN-COV is similarly recommended only for early use before severe symptoms can develop.
Once the initial surge of COVID-19 cases and deaths started in March-April 2020, the seasonal flu magically vanished along with Tamiflu despite some early indications that it works on COVID.
According to the FDA fact sheet on REGEN-COV, the intravenous infusion process it requires appears time-consuming (can take 20 to 50 minutes or more with a one-hour monitoring period immediately after). For now, it is recommended for use only on confirmed COVID-19 patients over the age of 12 who are at high risk of developing severe symptoms, but permits some flexibility to be given as a preventative to especially high-risk patients. It sounds so promising the FDA was careful to say it is not a substitute for the vaccines.
The FDA has known from the beginning that early treatment of COVID-19 is essential yet chose to ignore India’s great success with its initial early treatment protocol that initially included HCQ. However, when the delta variant arrived it appeared more resistant to HCQ, so India immediately approved and widely distributed a new more potent outpatient COVID kit consisting of Ivermectin, Doxcycline, and Zinc. This less than $3 kit quickly reversed the delta variant death trend there. Finding the true cost per-dose of REGEN-COV proved more elusive; ranging from $10 to $2,100 per dose. Grab your ‘Good Rx’ card just in case.